RE:RE:RE:RE:RE:RE:RE:RE:RE:Rusty is gonna SH1TI know THTX has also been extremely disappointed and frustrated with its valuation ... maybe they ran out of ways to try to move the SP ... or maybe they ran out of patience (we can call this Leah's punt). There is this noisy message board that we are all part of (remember when they blamed us?) ... maybe they felt compelled to make *SOMETHING* happen.
Let's see, maybe, just maybe we will be surprised.
-LT
scarlet1967 wrote: You have to understand the sale growth is real but as far as the R&D programs it's still early so I would be more comfortable to have any potential set back at higher valuation than the current valuation meaning the company should have waited till the SP was much higher than $2.75 US before dilution.
bfw wrote:
I don't think they care about credibility from retail investors.
They are more interested in getting the street on board.
I don't like the terms either but I'd rather have the street on Thera's side in the medium and longer term.
bfw
scarlet1967 wrote: It doesn't matter how you want to swing it they are displaying a weak confidence on the prospects on their future progress, weak and absolutely wrong method to build up that long lost credibility.
bfw wrote: Yeah, I tend to look at it the same way.
Disappointed short term but this is like paying the street to cover you and promote your stock. A steep price that leads to an ultimately lower peak but a quicker ride there.
These banksters will promoting Thera the rest of the year with the cancer study results and the initiation of NASH Phase 3.
If a tree falls in the forest and nobody is there....well now there will be many listening.
bfw
realitycheck4u wrote: Let me take a different approach here in explaining why this may work out for the better.
Retail shareholders, algos run by computers, and many many people like yourself, who look at a company, will rate them based on long term debt due dates, and cash in the bank, burn rate and pipeline - then sales/sales growth.
If by raising $40M USD now, they put several things right, then this could climb quicker on more credability, to allow them to build out another offering at $15+++$20+++ to growth this themselves, rather than just being bought. It's the start of a new Thera, rather than eating cheetos on the way higher.
So, I would say that you can be upset for just getting diluted, but I would also say that you should consider that this may be the thorn that works its way deep into the money pile.
SPCEO1 wrote: Sorry, I can't explain it. I saw the headline, called the CFO hoping to get some hidden insight that we all may have missed but unfortunately got no such explanation.
He suggested this would take care of their cash needs for two years and brings in some good new long term holders of the stock.
The credibility they were building - its now long gone. While obviously the company is now in better shape financially, there is nothing about this that makes any sense to me. Basically, it tells me the company has no confidence in their future as who would ever sell stock at these levels when you just got the phase III NASH news and your stock is so massively undervalued relative to all other NASH stocks??????????????????
Wow. So ugly.
Lee430 wrote: WTF is going on here? I simply feel blindsided and cheated, can someone please explain why this made sense right now?